SUBSCRIBE
SUBSCRIBE
Pharm Country

Biotechnology Industry Organization (BIO) Release: Regulatory, Health Experts Available to Comment on Follow-on Biologics

November 15, 2007 | 
1 min read
WHO: John M. Taylor, Executive Vice President for Health, Biotechnology Industry Organization (BIO). Sara Radcliffe, Vice President for Science and Regulatory Affairs, Biotechnology Industry Organization (BIO).
Events
MORE ON THIS TOPIC
Medical characters fighting the epidemic flat vector concept operation hand drawn illustration
Obesity
Analysts Home In on Safety as Novo, Lilly, Amgen Highlight Weight Loss Data at ADA
June 27, 2025
 · 
5 min read
 · 
Heather McKenzie
IN PARTNERSHIP WITH PATSNAP
Webinar: Beyond Theory: Real-World AI Wins in Life Science R&D, Faster & Smarter
June 25, 2025
 · 
1 min read
 · 
BioSpace Insights
Pictured: (From L) Joe Ross, Camille Bedrosian, Emil Kakkis and Heather McKenzie
Rare diseases
FDA Conditional Pathway Not Necessary, Rare Disease Experts Say, While Applauding Intent
June 24, 2025
 · 
3 min read
 · 
Heather McKenzie
From left to right: Jeff Quillen, Foley Hoag; Jim Cirenza, DNB Bank; Andrew Meadow, Health Innovation Capital; Greg Benning, Back Bay Life Science Advisors; Jonathan Gertler, Back Bay Life Science Advisors
Collaboration
Partner-Seeking Biotechs Find Plenty of Hands To Shake as BIO2025 Kicks Off
June 16, 2025
 · 
2 min read
 · 
Jef Akst